BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
575 results:

  • 1. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
    Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
    Lippert J; Smith G; Appenzeller S; Landwehr LS; Prete A; Steinhauer S; Asia M; Urlaub H; Elhassan YS; Kircher S; Arlt W; Fassnacht M; Altieri B; Ronchi CL
    Eur J Endocrinol; 2024 Mar; 190(3):234-247. PubMed ID: 38451242
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
    Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
    JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of a mobile health intervention based on multi-theory model of health behavior change on self-management in patients with differentiated thyroid cancer: protocol for a randomized controlled trial.
    Jiang Y; Sun X; Jiang M; Min H; Wang J; Fu X; Qi J; Yu Z; Zhu X; Wu Y
    Front Public Health; 2024; 12():1327442. PubMed ID: 38282759
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and clinical outcome of Ovarian cancer Patients.
    Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.
    Verdegaal EME; Santegoets SJ; Welters MJP; de Bruin L; Visser M; van der Minne CE; de Kok PM; Loof NM; Boekestijn S; Roozen I; Westra IM; Meij P; Van der Burg SH; Kroep JR
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37949617
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
    Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
    Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BRAF
    Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
    Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: clinical outcome after Long-term Follow-up.
    Ahn DW; Lee SH; Choi JH; Cho IR; Jang DK; Paik WH; Jeong JB; Ryu JK; Kim YT
    Gut Liver; 2024 Mar; 18(2):328-337. PubMed ID: 37840221
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Response of Locally Advanced Pancreatic cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and clinical outcome.
    Sharma NR; Lo SK; Hendifar A; Othman MO; Patel K; Mendoza-Ladd A; Verco S; Maulhardt HA; Verco J; Wendt A; Marin A; Schmidt CM; diZerega G
    Pancreas; 2023 Mar; 52(3):e179-e187. PubMed ID: 37782888
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
    La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
    Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
    Militello AM; Orsi G; Cavaliere A; Niger M; Avallone A; Salvatore L; Tortora G; Rapposelli IG; Giordano G; Noventa S; Giommoni E; Bozzarelli S; Macchini M; Peretti U; Procaccio L; Puccini A; Cascinu S; Montagna C; Milella M; Reni M
    Cancer Chemother Pharmacol; 2023 Dec; 92(6):501-510. PubMed ID: 37725113
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
    Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
    Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real time
    Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
    Oncotarget; 2023 Sep; 14():811-818. PubMed ID: 37713330
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Factors for Relapse in Patients With clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
    J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
    Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
    Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids.
    Wu YH; Chao HS; Chiang CL; Luo YH; Chiu CH; Yen SH; Liu CY; Chiou JF; Burnouf T; Chen YJ; Wang PY; Chao TY; Hsu SM; Lu LS
    Thorac Cancer; 2023 Sep; 14(25):2591-2600. PubMed ID: 37474689
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
    Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
    Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.